Asset Details
Do you wish to reserve the book?
Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract
Do you wish to request the book?
Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract
2012
Overview
Dietary fucoxanthin has been reported to exert several physiological functions, and fucoxanthinol is considered to be the primary active metabolite of fucoxanthin. However, there is no information about the pharmacokinetics of fucoxanthinol in human subjects. In the present study, eighteen human volunteers were orally administered kombu extract containing 31 mg fucoxanthin, and their peripheral blood was collected 5 min before and 0·5, 1, 2, 4, 8 and 24 h after the treatment. Plasma fucoxanthinol concentrations were measured by HPLC, and the pharmacokinetics of fucoxanthinol were as follows: maximum concentration, 44·2 nmol/l; time at maximum concentration, 4 h; terminal half-time, 7·0 h; area under the curve (AUC) for 1–24 h, 578·7 nmol/l × h; AUC(∞), 663·7 nmol/l × h. In addition to fucoxanthinol, we also attempted to detect amarouciaxanthin A, a hepatic metabolite of fucoxanthinol, using HPLC, but it was not present in the volunteers' plasma. On the other hand, a peak that was suspected to represent the cis-isomer of fucoxanthinol was found in the HPLC chromatogram. By comparing the present results with those of a previous study using mice, we found that the bioavailability and metabolism of fucoxanthinol differ between human subjects and mice.
Publisher
Cambridge University Press
Subject
/ beta Carotene - analogs & derivatives
/ Biological and medical sciences
/ blood
/ Chromatography, High Pressure Liquid
/ Dietary Supplements - analysis
/ Female
/ Fundamental and applied biological sciences. Psychology
/ high performance liquid chromatography
/ Humans
/ Male
/ mice
/ Vertebrates: anatomy and physiology, studies on body, several organs or systems
